Di W - Search Results

1

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.

Shi K, Yin X, Cai MC, Yan Y, Jia C, Ma P, Zhang S, Zhang Z, Gu Z, Zhang M, Di W, Zhuang G. Shi K, et al. Among authors: di w. Elife. 2019 May 3;8:e44306. doi: 10.7554/eLife.44306. Elife. 2019. PMID: 31050342 Free PMC article.

2

Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.

Zhang S, Lin QD, DI W. Zhang S, et al. Among authors: di w. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):522-31. doi: 10.1111/j.1525-1438.2006.00547.x. Int J Gynecol Cancer. 2006. PMID: 16681721

3

Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: therapeutic potential for ovarian cancer.

Zhang N, Wu ZM, McGowan E, Shi J, Hong ZB, Ding CW, Xia P, Di W. Zhang N, et al. Among authors: di w. Cancer Sci. 2009 Dec;100(12):2459-64. doi: 10.1111/j.1349-7006.2009.01340.x. Epub 2009 Sep 2. Cancer Sci. 2009. PMID: 19769630 Free PMC article.

4

Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.

Zhu J, Zhang S, Gu L, Di W. Zhu J, et al. Among authors: di w. Carcinogenesis. 2012 Dec;33(12):2334-43. doi: 10.1093/carcin/bgs278. Epub 2012 Sep 10. Carcinogenesis. 2012. PMID: 22964660

5

Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.

Yin X, Zhang N, Di W. Yin X, et al. Among authors: di w. Int J Gynecol Cancer. 2013 May;23(4):630-41. doi: 10.1097/IGC.0b013e3182892cee. Int J Gynecol Cancer. 2013. PMID: 23518861

6

Correlation of CD44v6 expression with ovarian cancer progression and recurrence.

Shi J, Zhou Z, Di W, Li N. Shi J, et al. Among authors: di w. BMC Cancer. 2013 Apr 8;13:182. doi: 10.1186/1471-2407-13-182. BMC Cancer. 2013. Retraction in: BMC Cancer. 2020 Mar 19;20(1):236. doi: 10.1186/s12885-020-06753-0 PMID: 23565736 Free PMC article. Retracted.

7

Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.

Wang Y, Liu P, Duan Y, Yin X, Wang Q, Liu X, Wang X, Zhou J, Wang W, Qiu L, Di W. Wang Y, et al. Among authors: di w. Biomaterials. 2014 Jan;35(3):983-92. doi: 10.1016/j.biomaterials.2013.09.062. Epub 2013 Oct 28. Biomaterials. 2014. PMID: 24176193

8

Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Liu T, Chen L, Sun X, Wang Y, Li S, Yin X, Wang X, Ding C, Li H, Di W. Liu T, et al. Among authors: di w. Tumour Biol. 2014 Mar;35(3):2427-36. doi: 10.1007/s13277-013-1322-x. Epub 2013 Nov 7. Tumour Biol. 2014. PMID: 24197980

9

[Risk of cervical cancer and precancerous diseases in the oral HPV carriers].

He YF, Zhang MY, Feng LD, Yin YH, Zhang R, Di W. He YF, et al. Among authors: di w. Zhonghua Fu Chan Ke Za Zhi. 2013 Aug;48(8):611-6. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24199928 Chinese.

10

High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.

He YF, Zhang MY, Wu X, Sun XJ, Xu T, He QZ, Di W. He YF, et al. Among authors: di w. PLoS One. 2013 Dec 6;8(12):e79769. doi: 10.1371/journal.pone.0079769. eCollection 2013. PLoS One. 2013. PMID: 24324582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

681 results

Search Page

Filters